These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 24570371)

  • 1. Single clinical isolates from acute uncomplicated urinary tract infections are representative of dominant in situ populations.
    Willner D; Low S; Steen JA; George N; Nimmo GR; Schembri MA; Hugenholtz P
    mBio; 2014 Feb; 5(2):e01064-13. PubMed ID: 24570371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic relatedness of the Escherichia coli fecal population and strains causing urinary tract infection in the same host.
    Bahadori M; Motamedifar M; Derakhshandeh A; Firouzi R; Motamedi Boroojeni A; Alinejad M; Naziri Z
    Microbiologyopen; 2019 Jun; 8(6):e00759. PubMed ID: 30358940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection.
    Toval F; Köhler CD; Vogel U; Wagenlehner F; Mellmann A; Fruth A; Schmidt MA; Karch H; Bielaszewska M; Dobrindt U
    J Clin Microbiol; 2014 Feb; 52(2):407-18. PubMed ID: 24478469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multilocus sequence typing of Escherichia coli isolates from urinary tract infection patients and from fecal samples of healthy subjects in a college community.
    Matsui Y; Hu Y; Rubin J; de Assis RS; Suh J; Riley LW
    Microbiologyopen; 2020 Jun; 9(6):1225-1233. PubMed ID: 32189451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virulence genes and phylogenetic groups of uropathogenic Escherichia coli isolates from patients with urinary tract infection and uninfected control subjects: a case-control study.
    Rezatofighi SE; Mirzarazi M; Salehi M
    BMC Infect Dis; 2021 Apr; 21(1):361. PubMed ID: 33865334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia coli ST131-
    Liu CM; Stegger M; Aziz M; Johnson TJ; Waits K; Nordstrom L; Gauld L; Weaver B; Rolland D; Statham S; Horwinski J; Sariya S; Davis GS; Sokurenko E; Keim P; Johnson JR; Price LB
    mBio; 2018 Aug; 9(4):. PubMed ID: 30154256
    [No Abstract]   [Full Text] [Related]  

  • 7. Genotypic analysis of uropathogenic Escherichia coli to understand factors that impact the prevalence of β-lactam-resistant urinary tract infections in a community.
    Tarlton NJ; Moritz C; Adams-Sapper S; Riley LW
    J Glob Antimicrob Resist; 2019 Dec; 19():173-180. PubMed ID: 30872040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-genome comparison of urinary pathogenic Escherichia coli and faecal isolates of UTI patients and healthy controls.
    Nielsen KL; Stegger M; Kiil K; Godfrey PA; Feldgarden M; Lilje B; Andersen PS; Frimodt-Møller N
    Int J Med Microbiol; 2017 Dec; 307(8):497-507. PubMed ID: 29031453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between phylogenetic groups, antibiotic resistance and patient characteristics in terms of adhesin genes in cystitis and pyelonephritis isolates of Escherichia coli.
    Er DK; Dundar D; Uzuner H; Osmani A
    Microb Pathog; 2015 Dec; 89():188-94. PubMed ID: 26518125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae.
    Spurbeck RR; Stapleton AE; Johnson JR; Walk ST; Hooton TM; Mobley HL
    Infect Immun; 2011 Dec; 79(12):4753-63. PubMed ID: 21911462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli clonal group A causing bacteraemia of urinary tract origin.
    Skjøt-Rasmussen L; Olsen SS; Jakobsen L; Ejrnaes K; Scheutz F; Lundgren B; Frimodt-Møller N; Hammerum AM
    Clin Microbiol Infect; 2013 Jul; 19(7):656-61. PubMed ID: 22784317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children.
    Yun KW; Kim HY; Park HK; Kim W; Lim IS
    J Microbiol Immunol Infect; 2014 Dec; 47(6):455-61. PubMed ID: 24064288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of chaperone-usher fimbriae and curli fimbriae among uropathogenic Escherichia coli.
    Golpasand T; Keshvari M; Behzadi P
    BMC Microbiol; 2024 Sep; 24(1):344. PubMed ID: 39271999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal composition of Escherichia coli causing community-acquired urinary tract infections in the State of Rio de Janeiro, Brazil.
    Dias RC; Marangoni DV; Smith SP; Alves EM; Pellegrino FL; Riley LW; Moreira BM
    Microb Drug Resist; 2009 Dec; 15(4):303-8. PubMed ID: 19857137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface display of uropathogenic Escherichia coli FimH in Lactococcus lactis: In vitro characterization of recombinant bacteria and its protectivity in animal model.
    Derakhshandeh S; Shahrokhi N; Khalaj V; Habibi M; Moazzezy N; Asadi Karam MR; Bouzari S
    Microb Pathog; 2020 Apr; 141():103974. PubMed ID: 31926238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Analysis of Uropathogenic E.coli Isolates from Urinary Tract Infections.
    Valadbeigi H; Esmaeeli E; Ghafourian S; Maleki A; Sadeghifard N
    Infect Disord Drug Targets; 2019; 19(3):322-326. PubMed ID: 30421685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
    Ejrnæs K
    Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131.
    Totsika M; Kostakioti M; Hannan TJ; Upton M; Beatson SA; Janetka JW; Hultgren SJ; Schembri MA
    J Infect Dis; 2013 Sep; 208(6):921-8. PubMed ID: 23737602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
    Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS
    Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel chaperone-effector-immunity system identified in uropathogenic
    Casiano González A; Pacheco Villanueva A; Castro-Alarcón N; Méndez J; Oropeza R; Martínez-Santos VI
    PeerJ; 2024; 12():e17336. PubMed ID: 38784397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.